• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生命末期的化疗:何时停止?

Chemotherapy at the end of life: up until when?

机构信息

Servicio de Oncología Médica y Cuidados Paliativos, Hospital Universitario Marqués de Valdecilla, Avd Valdecilla s/n, 39008, Santander, Cantabria, Spain.

出版信息

Clin Transl Oncol. 2012 Sep;14(9):667-74. doi: 10.1007/s12094-012-0847-6. Epub 2012 Jul 7.

DOI:10.1007/s12094-012-0847-6
PMID:22855142
Abstract

AIM

The aim of this study is to analyze the use of CT in terminal stage cancer and the percentage of patients who received UCPD in 2009 and 2010 on the Medical Oncology and Palliative Home Care integrated service (UCPD) ward of the Marqués de Valdecilla University Hospital.

METHOD

Retrospective analysis of death rate registered on the Medical Oncology ward for 2009 and 2010 and the recorded date of the last CT given. The data are analyzed using the SPSS version 15.0 statistic package. Data were obtained from the Database Minimum Set for oncology admissions.

RESULTS

The death rate on the Medical Oncology ward is 22-24%. Total number of cases studied is 303. 47% of patients are aged 60 or younger. 81.8% (248) received active cancer treatment; of these, 138 (55.6%) in the last month, and 84 (33.8%) in the last 2 weeks. Only 66 patients out of those who died on the ward (21%) were previously sent to the UCPD.

CONCLUSIONS

Even when it is known that the majority of cancer patients become resistant to CT at the end of their lives, it is often given to patients of all ages. The request for palliative care is rare and often late.

摘要

目的

本研究旨在分析 2009 年和 2010 年在马尔凯斯·德瓦尔德西利亚大学医院综合肿瘤医学和姑息家庭护理(UCPD)病房接受 UCPD 的终末期癌症患者的 CT 使用情况和 UCPD 使用率。

方法

对 2009 年和 2010 年肿瘤医学病房的死亡率和最后一次 CT 记录日期进行回顾性分析。使用 SPSS 版本 15.0 统计软件包对数据进行分析。数据来自肿瘤学入院数据库最小数据集。

结果

肿瘤医学病房的死亡率为 22-24%。研究的总病例数为 303 例。47%的患者年龄在 60 岁或以下。81.8%(248 例)接受了积极的癌症治疗;其中 138 例(55.6%)在最后一个月,84 例(33.8%)在最后两周。在病房死亡的 66 名患者中(21%)只有 66 名患者之前被送往 UCPD。

结论

尽管人们已经知道大多数癌症患者在生命的最后阶段对 CT 产生耐药性,但 CT 仍经常用于各个年龄段的患者。对姑息治疗的需求很少,而且往往很晚。

相似文献

1
Chemotherapy at the end of life: up until when?生命末期的化疗:何时停止?
Clin Transl Oncol. 2012 Sep;14(9):667-74. doi: 10.1007/s12094-012-0847-6. Epub 2012 Jul 7.
2
Trends in end-of-life decisions among patients dying in a university hospital oncology ward after implantation of a palliative outpatient clinic.在一所大学附属医院肿瘤科病房中,在姑息门诊植入后死亡的患者的临终决策趋势。
Acta Oncol. 2022 Jul;61(7):881-887. doi: 10.1080/0284186X.2022.2063068. Epub 2022 Apr 25.
3
Quality of end-of-life care of advanced cancer patients in mainland China-a retrospective cohort of 441 hospital-death in a public funded comprehensive hospital.中国大陆晚期癌症患者的临终关怀质量——一家公立综合医院441例医院死亡病例的回顾性队列研究
Ann Palliat Med. 2020 Nov;9(6):4514-4521. doi: 10.21037/apm-19-268. Epub 2020 Jul 14.
4
Polypharmacy in the terminal stage of cancer.癌症终末期的多重用药
Support Care Cancer. 2016 May;24(5):2067-2074. doi: 10.1007/s00520-015-3007-z. Epub 2015 Nov 5.
5
Prevalence of systemic anticancer therapy for patients within the last 30 days of life: experience in a private hospital oncology group.生命最后30天内患者接受全身抗癌治疗的患病率:一家私立医院肿瘤学团队的经验
Intern Med J. 2017 Mar;47(3):280-283. doi: 10.1111/imj.13260.
6
The utilization of palliative care in gynecologic oncology patients near the end of life.在妇科肿瘤患者生命末期对姑息治疗的利用。
Gynecol Oncol. 2012 Oct;127(1):175-9. doi: 10.1016/j.ygyno.2012.06.025. Epub 2012 Jun 24.
7
Integration of a palliative and terminal care center into a comprehensive pediatric oncology department.将姑息治疗和临终关怀中心纳入综合性儿科肿瘤科室。
Pediatr Blood Cancer. 2008 May;50(5):949-55. doi: 10.1002/pbc.21476.
8
The Impact of Integrated Home Palliative Care Services on Resource Use and Place of Death.综合家庭姑息治疗服务对资源利用和死亡地点的影响。
J Palliat Med. 2020 Jan;23(1):67-73. doi: 10.1089/jpm.2018.0639. Epub 2019 Sep 11.
9
Palliative Chemotherapy Near the End of Life in Oncology Patients.肿瘤患者生命末期的姑息性化疗
Am J Hosp Palliat Care. 2018 Sep;35(9):1215-1220. doi: 10.1177/1049909118763338. Epub 2018 Mar 12.
10
Chemotherapy use in end-of-life digestive cancer patients: a retrospective AGEO observational study.晚期消化道癌症患者化疗应用:一项回顾性 AGEO 观察性研究。
Clin Res Hepatol Gastroenterol. 2021 Sep;45(5):101709. doi: 10.1016/j.clinre.2021.101709. Epub 2021 Apr 27.

引用本文的文献

1
A taxonomy of the factors contributing to the overtreatment of cancer patients at the end of life. What is the problem? Why does it happen? How can it be addressed?一份关于导致癌症患者临终过度治疗因素的分类法。问题是什么?为何会发生?如何解决?
ESMO Open. 2025 Jan;10(1):104099. doi: 10.1016/j.esmoop.2024.104099. Epub 2025 Jan 6.
2
Unscheduled Hospital Admission as a Prognostic Factor in the Oncologic Patient: A Retrospective Study.非计划性住院作为肿瘤患者的预后因素:一项回顾性研究
Cureus. 2024 Oct 21;16(10):e72029. doi: 10.7759/cureus.72029. eCollection 2024 Oct.
3
Quality Assessment in Supportive Care in Head and Neck Cancer.

本文引用的文献

1
Limited impact of palliative chemotherapy on survival in advanced solid tumours in patients with poor performance status.在身体状况不佳的晚期实体瘤患者中,姑息性化疗对生存的影响有限。
Clin Transl Oncol. 2011 Jun;13(6):426-9. doi: 10.1007/s12094-011-0677-y.
2
Bending the cost curve in cancer care.控制癌症治疗成本
N Engl J Med. 2011 May 26;364(21):2060-5. doi: 10.1056/NEJMsb1013826.
3
[Chemotherapy at the end of life. Is it compassive?].[临终时的化疗。这是出于同情吗?]
头颈部癌症支持性护理中的质量评估
Front Oncol. 2019 Sep 18;9:926. doi: 10.3389/fonc.2019.00926. eCollection 2019.
4
Palliative care and end-of-life measure outcomes: Experience of a tertiary care institute from South India.姑息治疗与临终措施结果:印度南部一家三级医疗机构的经验
South Asian J Cancer. 2018 Jul-Sep;7(3):210-213. doi: 10.4103/sajc.sajc_257_17.
5
Trends in treatment during the last stages of life in end-stage gynecologic cancer patients who received active palliative chemotherapy: a comparative analysis of 10-year data in a single institution.在接受积极姑息化疗的晚期妇科癌症患者生命终末期治疗趋势:单一机构 10 年数据的对比分析。
BMC Palliat Care. 2018 Aug 7;17(1):99. doi: 10.1186/s12904-018-0348-7.
6
Treatment of cancer patients in their last month of life: aimless chemotherapy.癌症患者生命最后一个月的治疗:无意义的化疗。
Support Care Cancer. 2016 Apr;24(4):1603-8. doi: 10.1007/s00520-015-2959-3. Epub 2015 Sep 21.
7
Time from last chemotherapy to death and its correlation with the end of life care in a referral hospital.从上次化疗到死亡的时间及其与一家转诊医院临终关怀的相关性。
Indian J Med Paediatr Oncol. 2015 Jan-Mar;36(1):55-9. doi: 10.4103/0971-5851.151792.
8
Use of chemotherapy at the end of life in Turkey.土耳其临终时化疗的使用情况。
BMC Palliat Care. 2014 Nov 19;13(1):51. doi: 10.1186/1472-684X-13-51. eCollection 2014.
9
Association between the duration of palliative care service and survival in terminal cancer patients.姑息治疗服务时长与晚期癌症患者生存情况之间的关联。
Support Care Cancer. 2015 Apr;23(4):1057-62. doi: 10.1007/s00520-014-2444-4. Epub 2014 Oct 4.
10
Should be NICE have a Spanish NICE?英国国家卫生与临床优化研究所(NICE)应该有一个西班牙版的NICE吗?
Clin Transl Oncol. 2013 Jul;15(7):501-2. doi: 10.1007/s12094-013-1051-z. Epub 2013 Jun 6.
Med Clin (Barc). 2011 Mar 26;136(8):343-4. doi: 10.1016/j.medcli.2010.11.002.
4
Association between a name change from palliative to supportive care and the timing of patient referrals at a comprehensive cancer center.从姑息治疗到支持性治疗的名称变更与综合癌症中心患者转介时间的关联。
Oncologist. 2011;16(1):105-11. doi: 10.1634/theoncologist.2010-0161. Epub 2011 Jan 6.
5
Early palliative care for patients with metastatic non-small-cell lung cancer.转移性非小细胞肺癌患者的早期姑息治疗。
N Engl J Med. 2010 Aug 19;363(8):733-42. doi: 10.1056/NEJMoa1000678.
6
Availability and integration of palliative care at US cancer centers.美国癌症中心姑息治疗的可及性和整合。
JAMA. 2010 Mar 17;303(11):1054-61. doi: 10.1001/jama.2010.258.
7
Cancer in Spain.西班牙的癌症。
Clin Transl Oncol. 2010 Mar;12(3):158-9. doi: 10.1007/s12094-010-0484-x.
8
Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial.姑息治疗干预对晚期癌症患者临床结局的影响:ENABLE II项目随机对照试验
JAMA. 2009 Aug 19;302(7):741-9. doi: 10.1001/jama.2009.1198.
9
Factors that affect the duration of the interval between the completion of palliative chemotherapy and death.影响姑息性化疗结束至死亡间隔时间的因素。
Oncologist. 2009 Jul;14(7):752-9. doi: 10.1634/theoncologist.2008-0257. Epub 2009 Jul 11.
10
Discussions with physicians about hospice among patients with metastatic lung cancer.与医生就转移性肺癌患者的临终关怀问题进行的讨论。
Arch Intern Med. 2009 May 25;169(10):954-62. doi: 10.1001/archinternmed.2009.127.